Tumor immunogenicity reprogramming published in Acta Biomaterialia
Our latest research on enhancing immunotherapy efficacy by modulating the tumor immune microenvironment using biodegradable nanoparticles has been published in Acta Biomaterialia. The paper is titled “Degradation-Controlled Synchronization of HIF-2α and MEK Inhibition Using Self-Sealed Porous Silicon Nanoparticles to Reprogram Tumor Immunogenicity.” Juyoung led this study as the first author. This work represents a key […]
Read More »